HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$1.83
Day range
$1.64 - $1.96
Year range
$1.52 - $28.60
Market cap
3.61M USD
Avg Volume
677.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.09M | 158.49% |
Net income | -3.12M | -175.62% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.72M | -64.59% |
Total assets | 4.27M | -40.20% |
Total liabilities | 4.90M | 532.26% |
Total equity | -633.00K | — |
Shares outstanding | 2.02M | — |
Price to book | -4.46 | — |
Return on assets | -179.09% | — |
Return on capital | 7,461.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.12M | -175.62% |
Cash from operations | -3.50M | -349.61% |
Cash from investing | -250.00K | -105.88% |
Cash from financing | 3.44M | — |
Net change in cash | -346.00K | -109.95% |
Free cash flow | -2.37M | -586.63% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
5
